跳至主要内容
临床试验/PACTR202208496861650
PACTR202208496861650招募中未知

Efficacy and Safety of Labor Induction by Oral versus Vaginal Misoprostol: A Randomized Controlled Clinical Trial

Matega Habiragi0 个研究点目标入组 177 人开始时间: 2022年7月27日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
177

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • Nulliparous and multiparous,
  • followed prenatal counselling in one of the selected structures,
  • term pregnancy,
  • fetal heart sounds within the norms (110-160 beats per minute) and
  • cephalic presentation

排除标准

  • Women who have already given birth more than 5 times,
  • pregnant women with twin or multiple pregnancies,
  • gravid hypertension,
  • preeclampsia,
  • gestational diabetes or chronic unbalanced diabetes,
  • uterine height greater than 36 cm presentation other than cephalic,
  • fetal heart rhythm disorders before induction,
  • placenta previa,
  • pregnancy on fibromyomatous uterus,
  • petal-pelvic disproportion,
  • pelvic anomalies,
  • fetal death.

研究者

发起方
Matega Habiragi

相似试验